Archives: 2021-12-13

A new brief of Health System Tracker examines how deaths from COVID-19 rank among other leading causes of death in the U.S. and vaccine saving of 163.000 deaths since June 2021.

This brief examines how deaths from COVID-19 rank among other leading causes of death in the U.S. We find that COVID-19 was the third leading cause of death in November 2021. We also find that in October, COVID-19 was the number 1 cause of death for people age 45-54 and in the top 7 leading

Read More


Potentially Serious Side Effect Seen in Patient after CAR-T cell treatment for multiple myeloma

Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma. Their findings were published as a case study in Nature Medicine in December. Multiple myeloma is a complex and incurable type

Read More


Israel study shows that booster receivers at least 5 months after a second dose of BNT162b2 had 90% lower mortality due to Covid-19.

Booster doses of Pfizer’s coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest. Boosted folks are 90% less likely to die from a Delta infection than people relying solely on the initial two-dose vaccination, Israeli data show. That protection will be critically important

Read More


New Technology published by Caltech researchers is One Step Closer to Targeted Gene Therapy

Broad and robust transgene expression across brain regions of marmoset is shown after systemic delivery with engineered capsid. Gene therapy is a powerful developing technology that has the potential to address myriad diseases. For example, Huntington’s disease, a neurodegenerative disorder, is caused by a mutation in a single gene, and if researchers could go into

Read More


Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease.

Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of

Read More


3 Teens with COVID-19 Developed Sudden Severe Psychiatric Symptoms. Why?

UCSF-Led Study Shows Unruly Immune System May Trigger ‘Turncoat’ Antibodies Suicidal thoughts, “paranoia-like fears,” delusions and “foggy brain” have been identified in three adolescents who had mild or asymptomatic COVID-19. Now, a new study into their immune responses identifies a potential mechanism by which these symptoms emerged. The study, led by researchers at the UCSF Weill

Read More


Early Features on South Africa Tshwane District Omicron Variant Patient Profile: absence of any significant increase in in-hospitals deaths in relation to the dramatic rise in the case rate.

There has been a significant rise in new SARS-CoV-2 infections in the Gauteng Province in the last four weeks which has been attributed to the new Omicron variant announced on 24 November 2021. The first cases of Omicron were detected in the Tshwane District and coincided with the sharp rise in new infections, heralding the

Read More


The first six months of COVID-19 vaccination campaign in Italy averted 29350 deaths and 4256332 new infections: results published in a paper of Greenwich, Boston and Indiana Universities

In a paper published in MedRxiv are analyzed the effectiveness of the first six months of vaccination campaign against SARS-CoV-2 in Italy by using a computational epidemic model which takes into account demographic, mobility, vaccines, as well as estimates of the introduction and spreading of the more transmissible Alpha variant. Are considered six sub-national regions

Read More